Treatment Options for Covert Hepatic Encephalopathy
- 476 Downloads
Hepatic encephalopathy, even in its mildest form, can lead to significant deterioration in quality of life, lower overall survival, and add to caregiver burden. However, due to a paucity of symptoms, covert hepatic encephalopathy (CHE) is often ignored or neglected by physicians as well as patients. The lack of consensus among experts for both diagnosis as well as treatment of CHE adds to this problem. Treatment options for CHE include lactulose, rifaximin, ammonia scavengers, branched-chain amino acids, and probiotics. In this chapter we review the existing evidence on these agents and explain treatment decisions using a case-based approach.
KeywordsCovert hepatic encephalopathy Portosystemic shunt Psychometric hepatic encephalopathy score Minimal hepatic encephalopathy
American Association for the Study of Liver Diseases
Branched-chain amino acids
Critical flicker frequency
Covert hepatic encephalopathy
European Association for the Study of the Liver
Model for end-stage liver disease
Mini-mental state examination
Overt hepatic encephalopathy
Psychometric hepatic encephalopathy score
Spontaneous bacterial peritonitis
- 3.Ampuero J, Montoliú C, Simón-Talero M, et al. Minimal hepatic encephalopathy identifies patients at risk of faster cirrhosis progression. J Gastroenterol Hepatol. 2017. https://doi.org/10.1111/jgh.13917.
- 7.Mittal VV, Sharma BC, Sharma P, Sarin SK. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2011;23(8):725–32. https://doi.org/10.1097/MEG.0b013e32834696f5.CrossRefPubMedGoogle Scholar
- 13.Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK. Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME trial). Am J Gastroenterol. 2011;106(2):307–16. https://doi.org/10.1038/ajg.2010.455.CrossRefPubMedGoogle Scholar
- 17.Dalal R, Mcgee RG, Riordan SM, Webster AC. Probiotics for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;(2). https://doi.org/10.1002/14651858.CD008716.pub3.
- 21.Maharshi S, Sharma BC, Sachdeva S, Srivastava S, Sharma P. Efficacy of nutritional therapy for patients with cirrhosis and minimal hepatic encephalopathy in a randomized trial. Clin Gastroenterol Hepatol. 2016;14(3):454–460.e3.; quiz e33. https://doi.org/10.1016/j.cgh.2015.09.028.CrossRefPubMedGoogle Scholar
- 26.Bajaj JS, Kassam Z, Fagan A, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology. 2017. https://doi.org/10.1002/hep.29306.
- 27.Thumburu KK, Dhiman RK, Chopra M, et al. Comparative effectiveness of different pharmacological interventions for the treatment of minimal hepatic encephalopathy: a systematic review with network meta-analysis. J Clin Exp Hepatol. 2017;7:S6–7. https://doi.org/10.1016/j.jceh.2017.01.010.CrossRefGoogle Scholar